Page last updated: 2024-10-15

bis-(4-hydroxyiminomethylpyridinium)-2-trans-butene dibromide

Description

bis-(4-hydroxyiminomethylpyridinium)-2-trans-butene dibromide: reactivator of isopropyl-methylphosphonylated acetylcholinesterase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135539067
CHEMBL ID200983
MeSH IDM0043281

Synonyms (11)

Synonym
bieloxime
CHEMBL200983
pyridinium, 1,1'-(2-butene-1,4-diyl)bis(4-((hydroxyimino)methyl)-, dibromide, (?,?,e)-
bdb 108
hg 5
1,1'-(1,4-buten)-bis(4-hydroxyiminomethylpyridinium) dibromide
pyridinium, 1,1'-(2e)-2-butene-1,4-diylbis(4-((hydroxyimino)methyl)-, dibromide
28172-18-1
bdb-108
pyridinium, 1,1'-(2-butenylene)bis(formyl-, dibromide dioxime (?,?,e)-
bis-(4-hydroxyiminomethylpyridinium)-2-trans-butene dibromide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseRattus norvegicus (Norway rat)KR19.00003.00004.50006.0000AID302661
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID451155Permeability by PAMPA2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
AID451156Reactivation of diisopropylfluorophosphate-inhibited house fly AChE activity at 5 mM after 30 mins by Ellman's method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
AID302660Toxicity in intramuscular dosed rat after 24 hrs2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203).
AID307192Reactivation of 1000 uM tabun-induced inhibition of AChE in rat brain at pH 7.6 after 10 mins2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
AID301222Reactivation of 0.1 uM paraoxon-inhibited rat brain AchE2007Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21
Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.
AID301220Reactivation of 1 mM paraoxon-inhibited rat brain AchE2007Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21
Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.
AID260332Reactivation potency against inhibited AChE from rat brain homogenate at 1 mM2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase.
AID302659Reactivation activity of tabun-inhibited AChE in rat brain at 10 uM after 30 mins2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203).
AID307193Reactivation of 10 uM tabun-induced inhibition of AChE in rat brain at pH 7.6 after 10 mins2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
AID301219Reactivation of 1 mM tabun-inhibited rat brain AchE2007Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21
Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.
AID302661Binding affinity to tabun-inhibited AChE2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203).
AID302657Reactivation activity of tabun-inhibited AChE in rat brain at 1 mM after 30 mins2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203).
AID302658Reactivation activity of tabun-inhibited AChE in rat brain at 100 uM after 30 mins2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203).
AID307194Reactivation of 1000 uM paraoxon-induced inhibition of AChE in rat brain at pH 7.6 after 10 mins2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
AID451158Reactivation of diisopropylfluorophosphate-inhibited AChE activity in bovine red blood cell at 5 mM after 30 mins by Ellman's method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
AID307195Reactivation of 10 uM paraoxon-induced inhibition of AChE in rat brain at pH 7.6 after 10 mins2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
AID301221Reactivation of 0.1 uM tabun-inhibited rat brain AchE2007Bioorganic & medicinal chemistry, Nov-01, Volume: 15, Issue:21
Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.
AID260333Reactivation potency against inhibited AChE from rat brain homogenate at 0.01 mM2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase.
AID451159Reactivation of paraoxon-inhibited AChE activity in bovine red blood cell at 5 mM after 1 hr by Ellman's method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
AID451157Reactivation of paraoxon-inhibited house fly AChE activity at 5 mM after 1 hr by Ellman's method2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]